Novartis says Kisqali boosts survival in breast cancer patients

ZURICH: Novartis said on Sunday that Kisqali helped women with advanced breast cancer after menopause live longer, adding to data the Swiss company hopes will help convince doctors to choose its drug over Pfizer's blockbuster Ibrance.

Kisqali plus the hormone therapy fulvestrant, when compared to fulvestrant alone, demonstrated a significant improvement in survival with a 28per cent reduction in risk of death, Novartis said at the European Society for Medical Oncology meeting in Barcelona.Novartis said Kisqali is now the only drug of its kind to show positive overall survival in two pivotal studies.

The Basel-based firm said this year that Kisqali also boosted survival for women before menopause with hormone receptor positive, human epidermal growth factor receptor-2 negative advanced or metastatic breast cancer. "These results arm oncologists with more evidence to make a confident treatment choice for their hormone receptor-positive metastatic breast cancer patients," Dennis Slamon, a doctor at the University of California, Los Angeles Jonsson Comprehensive Cancer Center involved with the study, said in a statement.

Kisqali had US$235 million in sales in 2018, well behind US$4.1 billion for Ibrance, as Pfizer's first-to-market drug captured the lion's share of women with metastatic HR+/HER2- cancer.However, a Refinitiv poll found analysts expect Kisqali, priced at about US$130,000 per year, to have sales of about US$1.2 billion annually by 2024.

Source: News Formal (newsformal.com)

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bristol-Myers immunotherapy combo outperforms chemo in lung cancer survival: studyAbout 40per cent of patients who received a combination of Bristol-Myers Squibb Co's immuno-oncology drugs Opdivo and Yervoy as an initial ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Breast cancer survivor on folly of ‘Asian way’ of hiding illnesses after aunts failed to share own diagnosesHONG KONG — On a sunny afternoon in October last year, Hong Kong-born Kim Li could not have anticipated how her world would be turned upside down when her 14-year-old daughter Priya came home from school in tears, having discovered her school friend had just found a lump in her breast.
Source: TODAYonline - 🏆 1. / 99 Read more »

World News Day: Ghost patients, scammers haunt Philippine health systemAs a member of Philippine Health Insurance Corp (PhilHealth), patient Maria (not her real name) was getting free dialysis treatment at a city centre in Quezon, Philippines.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Ghost patients, scammers haunt Philippine health systemThis article has been published as part of World News Day (Sep 28), which celebrates the stories, the people, the reporting and the news ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Vape product concerns weigh on Canadian cannabis companies looking for sales boostA U.S. recommendation that consumers avoid vaping products containing the active ingredient in marijuana ahead of their legalization in Canada ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Separate GSK, AstraZeneca trial results may widen ovarian cancer drug useGlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a wider group of ovarian ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »